Skip to main
AMN
AMN logo

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services reported second-quarter revenue of $658.2 million, which, despite a year-over-year decline of 11%, surpassed both internal estimates and consensus expectations. The company also demonstrated improved operational efficiency, achieving a gross margin of 29.8%, exceeding its projected range and reflecting a sequential increase of 120 basis points. Furthermore, AMN's consistent track record of positive revenue and EBITDA surprises over the past four quarters—averaging +3% and +12%, respectively—reinforces a strong financial performance and a positive outlook for the company's stock.

Bears say

AMN Healthcare Services Inc reported a significant decline in revenue across its segments, with a 9% year-over-year decrease in the nurse and allied solutions segment and a 14% year-over-year decline in the physician and leadership solutions segment. The company also experienced a drop in operating margins, with the nurse and allied solutions segment's operating margin falling to 7.5% and a decrease in average travelers on assignment by 3% quarter-over-quarter. Furthermore, the vendor management system (VMS) revenue witnessed a sharp decline of 31% year-over-year, indicating a potential weakness in demand within its broader service offerings.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.